Hypertension (HTN) is a leading cause of death and disability in nearly half of all Americans. Alarmingly, almost 50% of individuals with HTN are unaware of their condition, and only about 20% have it under proper medical control. Nurse practitioners (NPs) play a crucial role in managing HTN, particularly in patient communication, shared decision-making and clinical expertise. On today’s episode, Dr. Leslie Davis and Maria Bonanni explore how renal denervation (RDN) reduces hypertension, and discuss clinical trials, patient selection and recent regulatory approvals. They also highlight the NP’s role in screening and educating patients about RDN through shared decision-making.

A participation code will be given at the END of the podcast - make sure to write this code down. Once you've listened to the podcast and have the participation code, return to this activity in the CE Center. Click on the "Next Steps" button of the activity and

1. Enter the participation code that was provided
2. Complete the post-test
3. Complete the activity evaluation. This will award your CE credit and certificate of completion.1.0 CE, through 09/30/25.

This activity is supported by an independent medical educational grant from Medtronics

Recorded live at the 2024 AANP National Conference, this episode of NP Pulse features a conversation with North Carolina-based nurse practitioner (NP), Meriah Ward, DNP, FNP-BC. Ward was diagnosed with autism in their thirties, and they are now sharing what they’ve learned as both a patient and provider to help inform other NPs as to how they can best treat individuals with autism spectrum disorder.

More than 19 million adults in the United States have been diagnosed with chronic obstructive pulmonary disease (COPD). Yet, due to the underdiagnosis and underreporting of symptoms which should be red-flag indicators of risk and the need for further investigation by health care providers, the prevalence of COPD is known to be much higher. Nurse practitioners (NPs) must be familiar with recent changes in diagnostic and treatment guidelines to impact the high burden of COPD and the significant amount of preventable complications which contribute to more than one-half million hospitalizations, 1.3 million emergency department visits and over 49.9 billion in annual health care costs in the U.S..

This accredited podcast and accompanying clinical resource tool is intended to help NPs:

• Recognize the diagnosis, assessment and treatment recommendations as delineated in the latest COPD guidelines, including the major changes introduced in the 2024 GOLD report.
• Differentiate the different treatment modalities for COPD and know when to use each treatment depending on patient group.
• Compare the emerging treatment modalities currently under investigation for the management of COPD.

A participation code will be given at the END of the podcast - make sure to write this code down. Once you've listened to the podcast and have the participation code, return to this activity in the CE Center. Click on the "Next Steps" button of the activity and

1. Enter the participation code that was provided
2. Complete the post-test
3. Complete the activity evaluation.

This will award your CE credit and certificate of completion.1.0 CE, 0.5 RX, through 9/3/25.

Click here to register for this activity.

This program is supported in part by an independent medical educational grant from Mylan Specialty L.P., a Viatris Company.